Functional Geriatric Assessment (F-Ga) In Multiple Myeloma Patients: Results From A Prospective Multicenter Study Group (Dsmm) Trial And Changes From Baseline To Follow-Up Assessment

Introduction: Due to continuous research and novel agents, today´s treatment choices for MM patients (pts) are numerous. In order to provide best tolerable and adjusted treatment, it is desirable to objectively assess individuals’ biological fitness and comorbidities (CM), rather than using pts’ chronological age alone (Bron et al. Haematologica 2016). Therefore, it is necessary to define new functional and geriatric test tools that are suitable to rate CM and therapy-related risks.